Evidence map›Paper›PMID 37922210›Full record

ArticleACS synthetic biology2023

Mammalian Genomic Manipulation with Orthogonal Bxb1 DNA Recombinase Sites for the Functional Characterization of Protein Variants.

Sarah M Roelle, Nisha D Kamath, Kenneth A Matreyek

Open access · hybridAbstract read
In one paragraph

Article in ACS synthetic biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sarah M RoelleDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, United States.
Nisha D KamathDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, United States.ORCID 0000-0001-8969-0631
Kenneth A MatreyekDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, United States.ORCID 0000-0001-9149-551X
University School · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Amar Desai · 1987 to 2026
$142.3M
Recombinant DNA technologies for multiplex genetic assays in human cellsR35GM142886 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI MATREYEK, KENNETH A · 2021 to 2025
$2.0M
Multiplex discovery of synthetic host-protein combinations that inhibit HIVR21AI156907 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI MATREYEK, KENNETH A · 2021 to 2022
$443k
Massively Parallel Mutational Analyses of Viral Neutralization Mechanisms Against Human Restriction FactorsK22AI141620 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI MATREYEK, KENNETH A · 2019 to 2020
$270k
Intermediate-Featured Flow CytometerS10OD021559 · OD · CASE WESTERN RESERVE UNIVERSITY · PI JACOBBERGER, JAMES W · 2016 to 2016
$230k
NCI NIH HHS P30 CA043703NIAID NIH HHS K22 AI141620NIAID NIH HHS R21 AI156907NIGMS NIH HHS R35 GM142886NIH HHS S10 OD021559
6 · The paper itself

Abstract

The Bxb1 bacteriophage serine DNA recombinase is an efficient tool for engineering recombinant DNA into the genomes of cultured cells. Generally, a single engineered "landing pad" site is introduced into the cell genome, permitting the integration of transgenic circuits or libraries of transgene variants. While sufficient for many studies, the extent of genetic manipulation possible with a single recombinase site is limiting and insufficient for more complex cell-based assays. Here, we harnessed two orthogonal Bxb1 recombinase sites to enable alternative avenues for using mammalian synthetic biology to characterize transgenic protein variants. By designing plasmids flanked by a second pair of auxiliary recombination sites, we demonstrate that we can avoid the genomic integration of undesirable bacterial DNA elements using the same starting cells engineered for whole-plasmid integration. We also created "double landing pad" cells simultaneously harboring two orthogonal Bxb1 recombinase sites at separate genomic loci, allowing complex cell-based genetic assays. Integration of a genetically encoded calcium indicator allowed for the real-time monitoring of intracellular calcium signaling dynamics, including kinetic perturbations that occur upon overexpression of the wild-type or variant version of the calcium signaling relay protein STIM1. A panel of missense mutants of the HIV-1 accessory protein Vif was paired with various paralogs within the human Apobec3 innate immune protein family to identify combinations capable or incapable of interacting within cells. These cells allow transgenic protein variant libraries to be readily paired with assay-specific protein partners or biosensors, enabling new functional readouts for large-scale genetic assays for protein function.

Indexed as

GenomeRecombinasesAnimalsDNAGenomicsHumansMammalsPlasmidsDNARecombinasesApobec3Bxb1GCaMPHIV-1 Viflanding padrecombinase

Identifiers

PMID37922210
PMCPMC10661055
OpenAlexW4388286632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.